Association Between Peri-Transfer Endometrial Peristalsis And Live Birth In Modified Natural Cycle Frozen Embryo Transfer: A Prospective Cohort Study
- Sponsor
- Mỹ Đức Hospital
- Study ID
- NCT07358468
- Status
- Recruiting
Conditions
- Endometrial Peristalsis
- Endometrial Waves
- Frozen Embryo Transfer (FET)
- Infertility
- Uterine Contraction
- Uterine Peristalsis
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 42 Years
- Healthy Volunteers
- Not accepted
Interventions
- Endometrial peristalsis and hormone measurements — OTHERTime point for measurement Endometrial peristalsis will be assessed at three specific time points: * On the second day to the fourth day of the menstrual cycle in the FET cycles. * The day of hCG trigger, (before progesterone exposure) * On the day of embryo transfer, immediately prior to the procedure Hormone measurements Serum levels of estradiol (E2) and progesterone (P4) will be assessed three times, on the same days as the endometrial peristalsis measurements, using electrochemiluminescence immunoassays. (Elecsys® Estradiol III and Elecsys® Progesterone III, Cobas® e 411, Roche Diagnostics, Germany): * On the second day to the fourth day of the menstrual cycle in the FET cycles * The day of hCG trigger * On the transfer day prior to the procedure.
Study Details
The uterus is a dynamic muscular organ that undergoes rhythmic, wave-like contractions known as endometrial peristalsis or endometrial waves. This muscular activity, which is an essential component of natural fertility, presents a nuanced and sometimes contradictory role in the context of assisted reproductive treatments. Endometrial peristalsis refers to the frequency, amplitude, and pattern of myometrial contractions occurring in different reproductive phases. These peristalsis play vital roles in sperm transport, embryo migration, and implantation. Clinical and imaging studies suggest that abnormal patterns or excessive contractility at the time of embryo transfer may disrupt endometrial-embryo synchrony, impair implantation, and increase miscarriage risk. However, most evidence on endometrial peristalsis pertains to fresh embryo transfer cycles, natural conceptions, or pathological contexts, such as adenomyosis or fibroids, with limited insights regarding its effects on different endometrial preparation protocols in frozen embryo transfer (FET). Understanding the dynamics of endometrial peristalsis in this context is clinically important, as inappropriate contractile activity could physically expel the embryo or create a non-receptive environment, ultimately reducing the chances of live birth. Despite its theoretical significance, there is a paucity of robust, prospective data correlating endometrial peristalsis patterns measured around the time of FET with different endometrial preparation protocols with subsequent pregnancy outcomes.
Key Dates
- First listed
- Jan 22, 2026
- Start date
- Feb 22, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 1, 2026
- Completion
- Dec 1, 2027
Study Design
- Enrollment
- 384 participants (estimated)
Arms
- Arm: Modified natural cycleOn modified natural cycle, when the mean diameter of the dominant follicle is ≥16 mm, human chorionic gonadotropin (hCG, Ovitrelle® 250 µg; Merck, USA or IVF-C 5000IU, LG Chem, Korea) will be injected to trigger ovulation. Vaginal progesterone (Cyclogest, LD Collins, UK) at a dose of 800 mg per day was started 2 days after hCG injection. Embryo transfer will be scheduled by the time of hCG trigger and embryo stages. Vaginal progesterone administration will be maintained until the day of the pregnancy test. In the event of a positive test result, luteal phase support will be extended until 10 weeks of gestation.
Primary Outcome Measure
The association between live birth and uterine contraction frequency measured at different time points. [ Time Frame: • On the second day to the fourth day of the menstrual cycle in the FET cycles. • The day of hCG trigger • On the day of embryo transfer, immediately prior to the procedure ]
Central Contacts
- Xuyen Thi Ha Le, MD+84945260494
- Tuong M Ho, MD+84903633377
Related Studies
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California
- Discarded Materials StudyRecruiting · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Study of Gene Associations and InfertilityEnrolling By Invitation · Reproductive Medicine Associates of New Jersey · Basking Ridge, New Jersey
- Inherited Reproductive DisordersRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Bethesda, Maryland